Study finds the timing of CSF biomarker divergence for Alzheimer disease, normal cognition varies

Cerebrospinal fluid (CSF) and other biomarkers differ for individuals with Alzheimer disease and cognitively normal controls, with the estimated times of divergence varying from 18 to six years before diagnosis, according to a

published in the Feb. 22 issue of the New England Journal of Medicine.

…